scholarly journals Editor and peer reviewer financial conflict of interest policies in public health journals

2020 ◽  
Vol 30 (6) ◽  
pp. 1230-1232
Author(s):  
Alyssa Ralph ◽  
Mark Petticrew ◽  
Andrew Hutchings
Keyword(s):  
Public Health ◽  
Conflict Of Interest ◽  
Health Research ◽  
Conflicts Of Interest ◽  
Financial Conflict ◽  
Disclosure Requirements ◽  
Financial Conflicts Of Interest

Abstract The influence of harmful commodity industries on health research has heightened concerns around author financial conflicts of interest (FCOIs) in public health journals (PHJs), with little discussion of potential editorial, i.e., editor and reviewer, FCOIs. In this analysis of 20 prominent PHJs, detailed disclosure requirements, the inclusion of timeframes, and policy accessibility were found lacking in editorial, compared with author, FCOI policies. Disclosure forms were employed in 32% of PHJs for authors but not for editors or reviewers. Recusal policies were similar for reviewers (68%) and editors (60%). Strengthening editorial FCOI policies will increase the integrity of PHJs’ editorial processes.

Financial Conflicts of Interest Are Common and Frequently Influence Conclusions of Economic Analyses Presented at the American Society of Hematology Annual Meeting.

Blood ◽  
2009 ◽  
Vol 114 (22) ◽  
pp. 810-810
Author(s):  
Sekwon Jang ◽  
Young Kwang Chae ◽  
Navneet S. Majhail
Keyword(s):  
Annual Meeting ◽  
Conflict Of Interest ◽  
Conflicts Of Interest ◽  
Pharmaceutical Product ◽  
Policy Implications ◽  
Financial Conflict ◽  
Essential Components ◽  
Financial Conflicts Of Interest ◽  
American Society ◽  
Economic Analyses

Abstract Abstract 810 Economic analyses of pharmaceutical agents are important determinants of health reimbursement decisions and are essential components of comparative effectiveness research. The American Society of Hematology (ASH) annual meeting is an important forum for presentation of economic analyses of hematology-oncology drugs. We hypothesized that economic analyses sponsored by pharmaceutical companies would be more likely to support that company's product. We conducted this study to determine the frequency of financial conflicts of interest in economic analyses presented at the ASH annual meeting and to examine whether such conflicts influenced study outcomes and directly or indirectly supported a specific product (an example of indirect support is a study on costs of febrile neutropenia sponsored by a pharmaceutical company that manufactures granulocyte colony-stimulating factor). ASH annual meeting abstracts from 2006-2008 were searched for economic analyses using following search terms: ‘cost', ‘economic', ‘dollar', ‘cost-effective', and ‘cost-benefit'. All abstracts in the ‘Health Services and Outcomes Research' category were also reviewed for economic analyses. Information was collected on the type of economic analysis, health technology assessed, author affiliation, the presence of conflict of interest and study conclusion. A total of 124 original economic analyses were identified. The majority of studies (52%) were conducted in the US, followed by Canada (11%) and UK (7%). Most studies were presented as a poster (61%). Eighty-seven studies (70%) evaluated a pharmaceutical product. First author affiliations included academic institutions (67%), consulting company employee (23%) and employee of sponsoring corporate (10%). Eighty-eight of 124 studies (71%) had at least one author with a financial conflict of interest. Studies with a conflict of interest were more likely to evaluate a pharmaceutical product than studies without a conflict of interest (81% vs. 44%, p<0.001). First authors of abstracts with a conflict of interest were less likely to be affiliated with an academic institution compared with abstracts without a conflict of interest (53% vs. 100%, p<0.001). The conclusions of 87 of 88 economic analyses with a conflict of interest favored the sponsor's product either directly (72%) or indirectly (27%). In conclusion, financial conflicts of interest are common in economic analyses presented at the ASH annual meeting. Almost all economic analyses with a financial conflict of interest support their sponsor's products. We could not exclude a publication bias, wherein economic analyses that did not favor a sponsor's product were less likely to be submitted for presentation. Economic analyses have important health policy implications and conflicts of interest should be carefully considered when interpreting the conclusions of economic analyses. Disclosures: No relevant conflicts of interest to declare.

scholarly journals Beyond financial conflicts of interest: Institutional oversight of faculty consulting agreements at schools of medicine and public health

PLoS ONE ◽  
2018 ◽  
Vol 13 (10) ◽  
pp. e0203179
Author(s):  
Michelle M. Mello ◽  
Lindsey Murtagh ◽  
Steven Joffe ◽  
Patrick L. Taylor ◽  
Yelena Greenberg ◽  
...  
Keyword(s):  
Public Health ◽  
Conflicts Of Interest ◽  
Financial Conflicts Of Interest ◽  
Institutional Oversight ◽  
Schools Of Medicine

Pitfalls in the publication of scientific literature: a road map to manage conflict of interest and other ethical challenges

2011 ◽  
Vol 114 (1) ◽  
pp. 21-26 ◽  
Author(s):  
Alpesh A. Patel ◽  
Peter G. Whang ◽  
Andrew P. White ◽  
Michael G. Fehlings ◽  
Alexander R. Vaccaro
Keyword(s):  
Conflict Of Interest ◽  
Scientific Literature ◽  
Conflicts Of Interest ◽  
Medical Writing ◽  
Data Accuracy ◽  
Ethical Challenges ◽  
Road Map ◽  
Current Article ◽  
Financial Conflicts Of Interest

The process of publishing scientific research can be hampered by potential pitfalls for journals and researchers alike; the definition and determination of authorship, legal documentation, data accuracy, and disclosure of financial conflicts of interest are all examples. In the current article, the authors discuss the challenges related to scientific medical writing and provide updated recommendations for both the prevention and management of these issues.

Curing Financial Conflicts of Interest in Psychiatric Professional Organizations

2014 ◽  
Author(s):  
Omar Sultan Haque ◽  
Alicia Lu ◽  
Daniel Wu ◽  
Lisa Cosgrove ◽  
Harold J. Bursztajn
Keyword(s):  
Public Health ◽  
Conflicts Of Interest ◽  
Evidence Base ◽  
Diagnosis And Treatment ◽  
Professional Organizations ◽  
Psychiatric Research ◽  
Sponsored Research ◽  
Normative Framework ◽  
Financial Conflicts Of Interest ◽  
Organized Psychiatry

Most of the attention to the problem of financial conflicts of interest (FCOI) in psychiatry has centered on the actions of individuals. But what if the problem is much larger, and has infected entire organizations? Using the conceptual, and normative framework of “institutional corruption,” we describe how organized psychiatry has developed values, norms, and practices that have undermined its public health mission. Specifically, we argue that institutionalized FCOI have distorted the evidence base upon which psychiatric research, diagnosis, and treatment depends. We argue that current strategies such as simple transparency of commercial ties and “managing” FCOI are insufficient and vulnerable to gamesmanship. Following the IOM’s most recent (2011) recommendations for preventing bias when there are academic–industry relationships, we offer ideas for responding to the ethical and intellectual crisis in psychiatry, and emphasize the importance of training practitioners to think critically when assessing the evidence base of industry-sponsored research.

PP172 Recruiting Academic Physicians Without Financial Conflict Of Interest

2017 ◽  
Vol 33 (S1) ◽  
pp. 146-146
Author(s):  
Jacques Belghiti ◽  
Stéphanie Luzio ◽  
David Fuks ◽  
Gregory Emery
Keyword(s):  
Medical Devices ◽  
Conflict Of Interest ◽  
Conflicts Of Interest ◽  
Complete Analysis ◽  
National Commission ◽  
Potential Conflict ◽  
Financial Conflict ◽  
Close Relationship ◽  
Before And After ◽  
Second Period

INTRODUCTION:To minimize the potential impact of conflicts of interest on health recommendations, several health institutions may be reluctant to recruit academic physicians due to their potential close relationship with industry. The present study aimed at evaluating the influence of academic physicians (AP) on the “rate of deport” due to financial support in the national commission of the HAS assessing medical devices.METHODS:After the renewal of this commission in November 2015, introducing patients representatives and more academic physicians, two periods of 12 months immediately before and after that date have been compared regarding the rate of deport during the sessions. Deport were decided by the legal section of our institution one week before each meeting according to a complete analysis of potential financial conflict of interest related to the medical device assessed. Only members without significant financial conflicts were allowed to participate to the discussion and the vote. The assessment of potential conflict of interest of all members followed the same criteria during the two periods.RESULTS:The number of physicians increased in the second period (nineteen versus twenty-three) with a significant higher rate of academic physicians (63 percent versus 82 percent, p = .001). The mean attendance of physicians was significantly lower during the second period (80 percent versus 65 percent, p = .03). During the two periods, the number of meetings (n = 22) was similar and the number of dossiers assessing new products was comparable (96 versus 104, p = .872). The decision to reimburse the medical devices was similar in the two periods (78 percent versus 73 percent, p = .681). The number of cases when physicians’ members were deported for conflict of interest was similar during the two periods (30 versus 28, p = .482) with not any increase among academic physicians.CONCLUSIONS:This study showed that it is possible to recruit several academic physicians without major financial conflicts of interest providing that their status could alter their assiduity.

scholarly journals A Procedure for Managing Conflict of Interest When Forming Thesis Juries

2018 ◽  
Vol 6 ◽  
Author(s):  
Bryn Williams-Jones
Keyword(s):  
Public Health ◽  
Conflict Of Interest ◽  
Conflicts Of Interest ◽  
Practical Procedure ◽  
School Of Public Health ◽  
Institutional Reputation ◽  
The University ◽  
Made In

Conflicts of interest in thesis juries, when not identified and appropriately managed, can lead to an uncritical and unfair evaluations that can then undermine trust in the process and threaten academic credibility and institutional reputation. This Commentary presents and justifies the choices made in developing a practical procedure to identify and manage conflicts of interest in the formation of Masters and PhD juries in the School of Public Health (ÉSPUM) at the University of Montreal.

scholarly journals The “throwaways”. Conflicts of interest in dermatology publications

2021 ◽  
Author(s):  
Jorge Roman ◽  
David J. Elpern
Keyword(s):  
Pharmaceutical Industry ◽  
Conflict Of Interest ◽  
Conflicts Of Interest ◽  
Board Members ◽  
Financial Conflict ◽  
News Magazines ◽  
The Impact ◽  
Open Payments ◽  
Clinical Dermatology

AbstractImportanceConflict of interest as it relates to medical education is a topic of concern. Dermatology journals, periodicals, editorials, and news magazines are influential resources that are not uniformly regulated and subject to influence from the pharmaceutical industry.ObjectiveThis study evaluates industry payments to physician editorial board members of common dermatology publications, including “throwaway” publications.DesignA list of editorial board members was compiled from a collection of clinical dermatology publications received over a 3-month period. To analyze the nature and extent of industry payments to this cohort, payments data from the Open Payments database from 2013 to 2019 were collected. Analysis of the total payments, number of transactions, categories of payments, payment sources, and physician specific characteristics was performed.ResultsTen publications were evaluated, and payments data for 466 physicians were analyzed. The total compensation across all years was $75,622,369.64. Services other than consulting, consulting, and travel/lodging payments comprised most of the payments. A faction of dermatologists received the majority of payments. The top payers were manufacturers of biologic medications. Payment amounts were higher for throwaway publications compared to peer-reviewed journals.ConclusionsEditorial board members of dermatology publications received substantial payments from the pharmaceutical industry. A minority of physicians receive the lion’s share of payments from industry. “Throwaway” publications have more financial conflict of interest than peer-reviewed journals. The impact of these conflicts of interest on patient care, physicians practice patterns, and patient perception of physicians is noteworthy.

Sign in / Sign up

Export Citation Format

Share Document